IBEX Technologies Overview

  • Founded
  • 1986
Founded
  • Status
  • Public
  • Employees
  • 9
Employees
  • Stock Symbol
  • IBT
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $0.42
  • (As of Friday Closing)

IBEX Technologies General Information

Description

Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays which have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, the U.S, U.K, and other countries of which the majority of the revenue is generated from the U.S.

Contact Information

Website
www.ibex.ca
Formerly Known As
Continental Pharma Cryosan, CPCI
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Medical Supplies
Other Industries
BPO/Outsource Services
Pharmaceuticals
Stock Exchange
TSX
Primary Office
  • 5485 Rue Pare
  • Suite 100
  • Montreal, Quebec H4P 1P7
  • Canada
+1 (514) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IBEX Technologies Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.42 $0.42 $0.21 - $0.47 $10.5M 24.8M 15.7K $0.04

IBEX Technologies Financials Summary

In Thousands,
USD
TTM 31-Jan-2022 FY 2021 31-Jul-2021 FY 2020 31-Jul-2020 FY 2019 31-Jul-2019
EV 4,665 3,093 4,073 432
Revenue 5,140 4,161 3,870 3,254
EBITDA 1,641 1,090 1,289 (991)
Net Income 1,143 597 717 (957)
Total Assets 8,404 7,580 6,405 6,378
Total Debt 449 494 395 755
Public Fundamental Data provided by Morningstar, Inc. disclaimer

IBEX Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IBEX Technologies‘s full profile, request access.

Request a free trial

IBEX Technologies Patents

IBEX Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-5205251-A Rotary valve for internal combustion engine Expired - Lifetime 05-Aug-1992 000000000 00

IBEX Technologies Executive Team (4)

Name Title Board Seat Contact Info
Paul Baehr Chief Executive Officer & Chairman
Belinda Franco Chief Financial Officer, Finance & Executive
Mahendra Pallapothu Vice President
You’re viewing 3 of 4 executive team members. Get the full list »

IBEX Technologies Board Members (5)

Name Representing Role Since
0000000 00000 IBEX Technologies Board Member 000 0000
0000 00000 IBEX Technologies Chief Executive Officer & Chairman 000 0000
000000 00000000 Self Board Member 000 0000
You’re viewing 3 of 5 board members. Get the full list »

IBEX Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IBEX Technologies Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000-00000000 31-Dec-2012 0000000000 00.000 Other Pharmaceuticals and Biotechnology
00000000 07-May-2007 0000000000 00.000 Personal Products 0000 0000
OncoTherapeutics 07-May-2003 Merger/Acquisition 00.000 BPO/Outsource Services 0000 0000
To view IBEX Technologies’s complete acquisitions history, request access »

IBEX Technologies Subsidiaries (1)

Company Name Industry Location Founded
000-00000000 00000 Other Pharmaceuticals and Biotechnology North Liberty, IA 0000
To view IBEX Technologies’s complete subsidiaries history, request access »

IBEX Technologies Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000000000 07-May-2003 000000000000000000 00.000 Completed
  • 0000 000000000000
To view IBEX Technologies’s complete exits history, request access »